Cheng‐Yi Lin

493 total citations
20 papers, 201 citations indexed

About

Cheng‐Yi Lin is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Cheng‐Yi Lin has authored 20 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Cheng‐Yi Lin's work include Colorectal Cancer Surgical Treatments (5 papers), Colorectal and Anal Carcinomas (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Cheng‐Yi Lin is often cited by papers focused on Colorectal Cancer Surgical Treatments (5 papers), Colorectal and Anal Carcinomas (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). Cheng‐Yi Lin collaborates with scholars based in Taiwan and China. Cheng‐Yi Lin's co-authors include Xiangyu Luo, Jun Zhang, Yufeng Tian, Li Zhang, Chien‐Feng Li, Yaling Li, Yuefeng Liu, Lei Chen, Ching‐Chieh Yang and Sung‐Wei Lee and has published in prestigious journals such as BMC Cancer, Aging and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.

In The Last Decade

Cheng‐Yi Lin

17 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng‐Yi Lin Taiwan 10 87 72 41 41 33 20 201
Zhongqi Wang China 10 157 1.8× 54 0.8× 91 2.2× 49 1.2× 56 1.7× 25 281
Naiqiang Zhu China 10 168 1.9× 34 0.5× 82 2.0× 37 0.9× 50 1.5× 17 303
Shudong Wang China 6 107 1.2× 38 0.5× 31 0.8× 19 0.5× 24 0.7× 14 234
Yuqing Zhang China 8 119 1.4× 80 1.1× 74 1.8× 15 0.4× 19 0.6× 16 261
Bastian Stoffers Germany 2 156 1.8× 34 0.5× 34 0.8× 15 0.4× 16 0.5× 3 295
Boqing Wang China 10 219 2.5× 50 0.7× 121 3.0× 19 0.5× 56 1.7× 23 330
Yujiao Sun China 9 109 1.3× 34 0.5× 42 1.0× 9 0.2× 22 0.7× 18 226
Wenyi Jiang China 10 140 1.6× 104 1.4× 60 1.5× 29 0.7× 34 1.0× 13 355
Qingjie Meng China 8 107 1.2× 22 0.3× 71 1.7× 20 0.5× 28 0.8× 16 239
Huimin Ding China 10 178 2.0× 36 0.5× 66 1.6× 15 0.4× 19 0.6× 18 282

Countries citing papers authored by Cheng‐Yi Lin

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Yi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Yi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Yi Lin more than expected).

Fields of papers citing papers by Cheng‐Yi Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Yi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Yi Lin. The network helps show where Cheng‐Yi Lin may publish in the future.

Co-authorship network of co-authors of Cheng‐Yi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Yi Lin. A scholar is included among the top collaborators of Cheng‐Yi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Yi Lin. Cheng‐Yi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yu‐Ching, et al.. (2024). Risk Factors and Nomogram Model for Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients with Low-Level Viremia. International Journal of Medical Sciences. 21(9). 1661–1671. 3 indexed citations
2.
3.
Chou, Chia‐Lin, Cheng‐Yi Lin, Wan‐Shan Li, et al.. (2024). Low CXCL11 expression is indicative of poor prognosis in rectal cancer patients undergoing preoperative chemoradiotherapy: a retrospective cohort study. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(4). 803–815. 1 indexed citations
4.
5.
Chou, Chia‐Lin, Tzu‐Ju Chen, Wan‐Shan Li, et al.. (2022). Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy. OncoTargets and Therapy. Volume 15. 1171–1181. 3 indexed citations
6.
Zhang, Yunqiang, et al.. (2021). Evaluation of the roles and regulatory mechanisms of PD-1 target molecules in NSCLC progression. Annals of Translational Medicine. 9(14). 1168–1168. 16 indexed citations
7.
Lin, Cheng‐Yi, Chia‐Lin Chou, Ching‐Chieh Yang, et al.. (2020). High EREG Expression Is Predictive of Better Outcomes in Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy. Oncology. 98(8). 549–557. 13 indexed citations
8.
Chen, Lei, et al.. (2020). <p>The Prognostic Value of Preoperative Geriatric Nutritional Risk Index in Patients with Pancreatic Ductal Adenocarcinoma</p>. Cancer Management and Research. Volume 12. 385–395. 21 indexed citations
9.
Sheu, Ming‐Jen, Chia‐Lin Chou, Ching‐Chieh Yang, et al.. (2020). Low BRCA2 expression predicts poor prognoses in patients with rectal cancer receiving chemoradiotherapy. Pathology - Research and Practice. 216(5). 152922–152922.
10.
Chou, Chia‐Lin, Tzu‐Ju Chen, Cheng‐Yi Lin, et al.. (2020). <p>PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis</p>. OncoTargets and Therapy. Volume 13. 3141–3150. 7 indexed citations
11.
Yang, Chun‐Chi, et al.. (2019). Shear wave elastography for differentiating biliary hamartoma from liver cirrhosis: A case series study and literature review. Advances in digestive medicine. 6(4). 158–164.
12.
Yang, Ching‐Chieh, Li‐Ching Lin, Yu‐Wei Lin, et al.. (2018). Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression. Oncology Letters. 17(2). 1551–1558. 10 indexed citations
13.
Tian, Yufeng, Hui‐Ching Wang, Chi‐Wen Luo, et al.. (2018). Preprogramming therapeutic response of PI3K/mTOR dual inhibitor via the regulation of EHMT2 and p27 in pancreatic cancer.. PubMed. 8(9). 1812–1822. 17 indexed citations
14.
Lin, Ching‐Yih, Yufeng Tian, Ding‐Ping Sun, et al.. (2017). High Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer. Journal of Cancer. 8(6). 1089–1096. 14 indexed citations
15.
Tian, Yu-Feng, Ding‐Ping Sun, Ming-Jen Sheu, et al.. (2017). Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy. Journal of Cancer. 8(8). 1330–1337. 16 indexed citations
16.
Guo, Jian, et al.. (2016). Phosphoinositide 3-kinase inhibitor LY294002 ameliorates the severity of myosin-induced myocarditis in mice. Current Research in Translational Medicine. 64(1). 21–27. 7 indexed citations
17.
Luo, Xiangyu, et al.. (2014). Andrographolide inhibits proliferation of human lung cancer cells and the related mechanisms.. PubMed. 7(11). 4220–5. 29 indexed citations
18.
Zhang, Jun, et al.. (2014). Effects of ethyl pyruvate on cardiac function recovery and apoptosis reduction after global cold ischemia and reperfusion. Experimental and Therapeutic Medicine. 7(5). 1197–1202. 15 indexed citations
19.
Liu, Yuefeng, et al.. (2013). Andrographolide inhibits the activation of NF-κB and MMP-9 activity in H3255 lung cancer cells. Experimental and Therapeutic Medicine. 6(3). 743–746. 26 indexed citations
20.
Wang, Jianjun, et al.. (2012). Clinical analysis of preoperative induction chemotherapy with gemcitabine combined with cisplatin for locally advanced non-small cell lung cancer. The Chinese-German Journal of Clinical Oncology. 11(5). 266–270. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhongqi Wang Breakdown of academic impact, for papers by Naiqiang Zhu Breakdown of academic impact, for papers by Shudong Wang Breakdown of academic impact, for papers by Yuqing Zhang Breakdown of academic impact, for papers by Bastian Stoffers Breakdown of academic impact, for papers by Boqing Wang Breakdown of academic impact, for papers by Yujiao Sun Breakdown of academic impact, for papers by Wenyi Jiang Breakdown of academic impact, for papers by Qingjie Meng Breakdown of academic impact, for papers by Huimin Ding
Rankless by CCL
2026